MoneyWorks4Me

Biocon informs about press release

03 Oct 2024 Evaluate

Further to its intimation dated September 24, 2024, Biocon has informed that it attached press release dated October 03, 2024, titled ‘Biocon Biologics Refinances USD 1.1 Billion (INR 93,468 million) Long Term Debt through USD Bonds and New Syndicated Facility’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..